These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 26485247

  • 1. Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?
    Ye Y, Kong Y, Zhang Y.
    Gynecol Obstet Invest; 2016; 81(1):28-33. PubMed ID: 26485247
    [Abstract] [Full Text] [Related]

  • 2. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.
    Regal JF, Strehlke ME, Peterson JM, Wing CR, Parker JE, Nieto NF, Bemis LT, Gilbert JS, Fleming SD.
    Mol Immunol; 2016 Oct; 78():38-47. PubMed ID: 27588825
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies.
    Lim R, Lappas M.
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):194-8. PubMed ID: 22901903
    [Abstract] [Full Text] [Related]

  • 4. [Expression and significance of AT1-AA and ET1 in materal peripheral blood, umbilical cord blood and placenta in preeclampsia].
    Zhao XL, Liu Z, Liu C.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):721-5. PubMed ID: 23302726
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
    Yu Y, Zhang L, Xu G, Wu Z, Li Q, Gu Y, Niu J.
    Kidney Blood Press Res; 2018 Oct; 43(5):1666-1676. PubMed ID: 30380548
    [Abstract] [Full Text] [Related]

  • 6. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
    Wang W, Irani RA, Zhang Y, Ramin SM, Blackwell SC, Tao L, Kellems RE, Xia Y.
    Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
    [Abstract] [Full Text] [Related]

  • 7. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H, Fisher AJ, Mickler EA, Duerson F, Cummings OW, Peters-Golden M, Twigg HL, Woodruff TM, Wilkes DS, Vittal R.
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
    Zhang S, Zheng R, Yang L, Zhang X, Zuo L, Yang X, Bai K, Song L, Tian J, Yang J, Liu H.
    J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia.
    Yang J, Li L, Shang JY, Cai L, Song L, Zhang SL, Li H, Li X, Lau WB, Ma XL, Liu HR.
    J Hypertens; 2015 May; 33(5):1046-56. PubMed ID: 25693057
    [Abstract] [Full Text] [Related]

  • 10. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
    Liu L, Zhang Y, Duan X, Peng Q, Liu Q, Zhou Y, Quan S, Xing G.
    J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
    [Abstract] [Full Text] [Related]

  • 11. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
    Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
    [Abstract] [Full Text] [Related]

  • 12. Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum.
    Rieber-Mohn AB, Sugulle M, Wallukat G, Alnæs-Katjavivi P, Leite Størvold G, Bolstad N, Redman CW, Dechend R, Staff AC.
    J Reprod Immunol; 2018 Aug; 128():23-29. PubMed ID: 29843114
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
    Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, Redman CW, Dechend R.
    Hypertension; 2009 Feb; 53(2):393-8. PubMed ID: 19064815
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis.
    Jun SW, Kim TH, Lee HM, Lee SH, Kim WJ, Park SJ, Kim YS, Lee SH.
    J Allergy Clin Immunol; 2008 Jul; 122(1):119-25. PubMed ID: 18538384
    [Abstract] [Full Text] [Related]

  • 15. Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation.
    Bai K, Wang K, Li X, Wang J, Zhang J, Song L, Wang J, Zhang S, Lau WB, Ma X, Liu H.
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):749-55. PubMed ID: 23681235
    [Abstract] [Full Text] [Related]

  • 16. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y, Yan X, Zhao T, Xu Q, Peng Q, Hu R, Quan S, Zhou Y, Xing G.
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [Abstract] [Full Text] [Related]

  • 17. Cadmium-induced immune abnormality is a key pathogenic event in human and rat models of preeclampsia.
    Zhang Q, Huang Y, Zhang K, Huang Y, Yan Y, Wang F, Wu J, Wang X, Xu Z, Chen Y, Cheng X, Li Y, Jiao J, Ye D.
    Environ Pollut; 2016 Nov; 218():770-782. PubMed ID: 27511439
    [Abstract] [Full Text] [Related]

  • 18. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
    Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, Cheng X, Zhang M, Ma XL, Liu H.
    J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
    [Abstract] [Full Text] [Related]

  • 19. Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease.
    Patzelt J, Mueller KA, Breuning S, Karathanos A, Schleicher R, Seizer P, Gawaz M, Langer HF, Geisler T.
    Atherosclerosis; 2015 Feb; 238(2):289-95. PubMed ID: 25544179
    [Abstract] [Full Text] [Related]

  • 20. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L, Chen L, Zang J, Tang X, Liu Y, Zhang J, Bai L, Yin Q, Lu Y, Cheng J, Fu P, Liu F.
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.